AMA
Wysoczańska-Klaczyńska A, Ślęzak A, Hetman M, Barg E. The impact of VDR gene polymorphisms on obesity, metabolic changes, bone mass disorders and neoplastic processes. Pediatric Endocrinology Diabetes and Metabolism. 2018;24(2):96-105.
APA
Wysoczańska-Klaczyńska, A., Ślęzak, A., Hetman, M., & Barg, E. (2018). The impact of VDR gene polymorphisms on obesity, metabolic changes, bone mass disorders and neoplastic processes. Pediatric Endocrinology Diabetes and Metabolism, 24(2), 96-105.
Chicago
Wysoczańska-Klaczyńska, Anna, Aleksandra Ślęzak, Marta Hetman, and Ewa Barg. 2018. "The impact of VDR gene polymorphisms on obesity, metabolic changes, bone mass disorders and neoplastic processes". Pediatric Endocrinology Diabetes and Metabolism 24 (2): 96-105.
Harvard
Wysoczańska-Klaczyńska, A., Ślęzak, A., Hetman, M., and Barg, E. (2018). The impact of VDR gene polymorphisms on obesity, metabolic changes, bone mass disorders and neoplastic processes. Pediatric Endocrinology Diabetes and Metabolism, 24(2), pp.96-105.
MLA
Wysoczańska-Klaczyńska, Anna et al. "The impact of VDR gene polymorphisms on obesity, metabolic changes, bone mass disorders and neoplastic processes." Pediatric Endocrinology Diabetes and Metabolism, vol. 24, no. 2, 2018, pp. 96-105.
Vancouver
Wysoczańska-Klaczyńska A, Ślęzak A, Hetman M, Barg E. The impact of VDR gene polymorphisms on obesity, metabolic changes, bone mass disorders and neoplastic processes. Pediatric Endocrinology Diabetes and Metabolism. 2018;24(2):96-105.
